AMETEK Acquires LKC Technologies

AMETEK (NYSE: AME) announced on February 3, 2026 the acquisition of LKC Technologies, a provider of portable diagnostic devices for ophthalmic conditions, joining AMETEK's Electronic Instruments Group (EIG).

Rhea-AI Summary

AMETEK (NYSE: AME) announced on February 3, 2026 the acquisition of LKC Technologies, a provider of portable diagnostic devices for ophthalmic conditions, joining AMETEK's Electronic Instruments Group (EIG).

The deal expands AMETEK's ophthalmic product portfolio, aligns LKC with the Ultra Precision Technologies Reichert business, and supports market expansion in eye‑care diagnostics. AMETEK reported annual sales of approximately $7.5 billion and reaffirmed its growth model emphasizing strategic acquisitions and double‑digit EPS growth over the cycle.

Positive

• Acquisition announced on February 3, 2026, adding LKC Technologies
• Expands ophthalmic portfolio under Ultra Precision Technologies Reichert
• Company scale: AMETEK reported approximately $7.5 billion annual sales

Negative

• None.

Argus Feb 3 session

+0.53% close to close Open Argus

Details

News Market Reaction – AME

In the Feb 3 session, AME gained 0.53%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights AMETEK’s continued use of acquisitions to broaden its portfolio, this t...

Analysis

This announcement highlights AMETEK’s continued use of acquisitions to broaden its portfolio, this time adding LKC’s ophthalmic diagnostic tools into the Electronic Instruments Group. It builds on prior deals like FARO, Kern, and Virtek that extended precision and measurement capabilities. Investors might track how LKC’s technologies integrate alongside AMETEK’s existing Ultra Precision businesses, the contribution toward its $7.5 billion sales base, and any follow-up disclosures in future earnings calls.

Key Figures

Annual sales: approximately $7.5 billion Founded: 1930 NYSE listing tenure: over 95 years

Annual sales

approximately $7.5 billion

Corporate profile in acquisition release

Founded

1930

Company history in corporate profile

NYSE listing tenure

over 95 years

AMETEK listing history in corporate profile

Previous Acquisition Reports

4 past events · Latest: Jul 21

Same Type 4 events

1. Jul 21

   Acquisition closing

   24h Move

   -0.2%

   Completion of FARO Technologies acquisition and integration into Ultra Precision.

2. May 06

   Acquisition agreement

   24h Move

   -1.4%

   Definitive agreement to acquire FARO Technologies at a cash premium.

3. Feb 04

   Acquisition announcement

   24h Move

   -2.0%

   Acquisition of Kern Microtechnik to add ultra-precision machining solutions.

4. Oct 31

   Acquisition announcement

   24h Move

   +8.5%

   Acquisition of Virtek Vision International expanding laser projection offerings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ophthalmic, diabetic retinopathy, s&p 500

3 terms

ophthalmic medical

"innovative technologies to enable the effective diagnosis and management of ophthalmic conditions"

Relating to the eye and its care, including medicines, drops, diagnostic tools and surgical devices used to prevent, diagnose or treat eye conditions. Investors care because ophthalmic products form a distinct market with specialized safety approvals, manufacturing needs and payer coverage, so success or failure in this area can drive steady revenue or costly setbacks—think of it as a niche, high‑safety consumer product line for vision health.

diabetic retinopathy medical

"designed to detect early signs of diabetic retinopathy and other serious eye conditions"

Diabetic retinopathy is an eye disease where prolonged high blood sugar damages the tiny blood vessels and nerve tissue at the back of the eye, leading to blurred vision or blindness if untreated. Investors track it because the condition affects a large, growing patient population and drives demand for screening tools, drugs, surgical devices and long-term care—think of it like damaged wiring in a camera that creates a market for repairs and upgrades.

s&p 500 financial

"has been listed on the NYSE for over 95 years and is a component of the S&P 500."

The S&P 500 is a broad stock market index that tracks the performance of 500 large U.S. companies, weighted so bigger firms have a larger impact. Investors use it like a thermometer or benchmark to judge how the overall U.S. stock market or a portfolio is doing; movements in the index influence investor sentiment, fund performance, and many passive investment products that aim to match its returns.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BERWYN, Pa., Feb. 3, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced the acquisition of LKC Technologies, a leading provider of innovative technologies to enable the effective diagnosis and management of ophthalmic conditions. 

LKC Technologies develops portable devices that help doctors test and monitor eye health. These innovative tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss.

"We are excited to welcome LKC Technologies to AMETEK," said David A. Zapico, AMETEK Chairman and Chief Executive Officer. "LKC Technologies is an excellent strategic fit with our Ultra Precision Technologies Reichert business, providing attractive market expansion opportunities and creating a broader ophthalmic product portfolio.  We look forward to leveraging our respective design and engineering capabilities to further advance patient eye healthcare together."   

LKC Technologies is headquartered in Germantown, MD. They will join AMETEK as part of its Electronic Instruments Group (EIG), a worldwide leader in the design and manufacture of advanced analytical, test and measurement instrumentation for aerospace, medical, power, energy, research and industrial markets.

Corporate Profile
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 95 years and is a component of the S&P 500. For more information, visit www.ametek.com.

Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
kevin.coleman@ametek.com
Phone: 610-889-5247

View original content:https://www.prnewswire.com/news-releases/ametek-acquires-lkc-technologies-302676826.html

SOURCE AMETEK, Inc.

FAQ

What did AMETEK (AME) announce about LKC Technologies on February 3, 2026?

AMETEK announced it acquired LKC Technologies to expand ophthalmic diagnostics. According to the company, LKC will join AMETEK's Electronic Instruments Group and integrate with the Ultra Precision Technologies Reichert business to broaden the ophthalmic product portfolio.

How does the LKC acquisition affect AMETEK's product lineup and market focus (AME)?

The acquisition broadens AMETEK's ophthalmic diagnostic offerings and market reach. According to the company, LKC's portable devices complement Reichert's precision technologies and create opportunities for expanded eye‑care product solutions and market expansion.

Will the LKC Technologies acquisition materially change AMETEK's size or revenue (AME)?

The announcement does not disclose a purchase price or expected immediate revenue impact. According to the company, AMETEK reported about $7.5 billion in annual sales and views the deal as a strategic expansion of its ophthalmic portfolio.

Which AMETEK division will LKC Technologies join after the acquisition (AME)?

LKC Technologies will join AMETEK's Electronic Instruments Group (EIG) as part of the deal. According to the company, EIG is responsible for analytical, test and measurement instrumentation across medical and industrial markets.

What strategic rationale did AMETEK (AME) provide for acquiring LKC Technologies?

AMETEK said the acquisition is a strategic fit to expand market opportunities in ophthalmics. According to the company, combining LKC with Reichert aims to leverage design and engineering capabilities to advance patient eye healthcare and product offerings.